Innovation overload: JNJ talks new science born from old world business strategy
This article was originally published in Scrip
Executive Summary
Proximity is the key for future developments in science, Johnson and Johnson's UK innovation head Patrick Verheyen has told Scrip in a discussion surrounding the big pharma's 2014 goals for its globally scattered innovation centers, since their launch nearly a year ago.